Program Leader of Stem Cells Australia, University of Melbourne
Professor Melissa Little is the Theme Director of Cell Biology at the Murdoch Childrens Research Institute, Royal Children’s Hospital, Melbourne and is both the Program Leader of Stem Cells Australia and a Professor in the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne, Australia. She is also the President of The Australian Society of Stem Cell Research.
For more than 20 years her research has focussed on the molecular basis of kidney development, renal disease and repair. She is internationally recognised for her work on the systems biology of kidney development and also her pioneering studies into potential regenerative therapies in the kidney. Her work on the developing kidney has driven studies into the recreation of nephron stem cell populations via transcriptional reprogramming and directed differentiation of pluripotent stem cells. As a result, her research now focuses on the generation of mini-kidneys from stem cells for use in drug screening and disease modelling and bioengineering. A Fellow of the Australian Academy of Health and Medical Sciences, Professor Little’s work has been recognised by many awards, including the GlaxoSmithKline Award for Research Excellence (2005), AAS Gottschalk Medal in Medical Sciences (2004), Eisenhower Fellowship (2006), ANZSCDB Presidents Medal (2015) and a Boerhaave Professorship, Leiden University (2015). A graduate of the Australian Institute of Company Directors, she founded Nephrogenix Pty Ltd and from 2007-2008, she served as the Chief Scientific Officer at the Australian Stem Cell Centre.
Melissa currently serves as a Special Editor for Development and on the editorial board of the Journal of the American Society for Nephrology, Kidney International and Developmental Biology.
New global guidelines for stem cell research aim to drive discussions, not lay down the law
May 28, 2021 11:13 am UTC| Law Science
The International Society for Stem Cell Research (ISSCR) today released updated guidelines for stem cell research and its translation to medicine. Developed in response to recent scientific and clinical advances, the...
The future of stem cells: tackling hype versus hope
Jan 29, 2017 23:18 pm UTC| Science
For many people suffering from disabling conditions, such as Parkinsons disease, spinal injury and paralysis, multiple sclerosis, macular degeneration, heart disease, renal failure and even cancer, announcements in the...
Labour can afford to be far more ambitious with its economic policies – voters are on board
Elon Musk vs Australia: global content take-down orders can harm the internet if adopted widely